AbbVie (WBO:ABBV) Other Operating Expense : €-156 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is AbbVie Other Operating Expense?

AbbVie's Other Operating Expense for the three months ended in Dec. 2023 was €-0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-156 Mil.

AbbVie's quarterly Other Operating Expense increased from Jun. 2023 (€-156 Mil) to Sep. 2023 (€0 Mil) but then declined from Sep. 2023 (€0 Mil) to Dec. 2023 (€-0 Mil).

AbbVie's annual Other Operating Expense declined from Dec. 2021 (€382 Mil) to Dec. 2022 (€53 Mil) and declined from Dec. 2022 (€53 Mil) to Dec. 2023 (€-164 Mil).

AbbVie Other Operating Expense Historical Data

The historical data trend for AbbVie's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Other Operating Expense Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-801.00

382.32

52.86

-164.14

AbbVie Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															-9.34	-155.99	-	-	-

AbbVie Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-156 Mil.

AbbVie Other Operating Expense Related Terms

Thank you for viewing the detailed overview of AbbVie's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (WBO:ABBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV34:Brazil

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.